Schiavoni, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 979
AS - Asia 804
EU - Europa 644
SA - Sud America 158
AF - Africa 20
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.610
Nazione #
US - Stati Uniti d'America 941
SG - Singapore 379
CN - Cina 188
IT - Italia 159
BR - Brasile 129
DE - Germania 111
SE - Svezia 102
FR - Francia 99
VN - Vietnam 62
GB - Regno Unito 40
IN - India 28
FI - Finlandia 27
CA - Canada 26
IE - Irlanda 25
JP - Giappone 25
ID - Indonesia 22
BD - Bangladesh 19
KR - Corea 19
HK - Hong Kong 14
ES - Italia 13
RU - Federazione Russa 13
TR - Turchia 12
AR - Argentina 11
PL - Polonia 10
NL - Olanda 9
ZA - Sudafrica 8
MX - Messico 7
AT - Austria 6
IQ - Iraq 6
BE - Belgio 5
IR - Iran 5
UA - Ucraina 5
EC - Ecuador 4
MA - Marocco 4
PT - Portogallo 4
SA - Arabia Saudita 4
AU - Australia 3
CH - Svizzera 3
CO - Colombia 3
CZ - Repubblica Ceca 3
VE - Venezuela 3
AZ - Azerbaigian 2
CL - Cile 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
LV - Lettonia 2
NP - Nepal 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
PR - Porto Rico 2
UY - Uruguay 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
HR - Croazia 1
JO - Giordania 1
KW - Kuwait 1
LT - Lituania 1
MK - Macedonia 1
MM - Myanmar 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 2.610
Città #
Singapore 235
Ashburn 124
San Jose 102
Chandler 80
New York 48
Beijing 44
Los Angeles 40
The Dalles 38
Rome 34
Hefei 32
Frankfurt am Main 26
Dublin 23
Milan 23
Tokyo 22
Hanoi 21
Ho Chi Minh City 21
Jakarta 19
Lauterbourg 18
Marseille 18
Munich 18
Seoul 18
Helsinki 16
Hong Kong 13
Boardman 12
Council Bluffs 12
Houston 12
São Paulo 12
Boston 11
Paris 11
Montreal 10
Nuremberg 10
Kent 9
Moscow 9
Poplar 9
Brooklyn 8
Buffalo 8
Denver 8
Memphis 8
North Bergen 8
Princeton 8
Santa Clara 8
Toronto 8
Dallas 7
Jacksonville 7
Nanjing 7
Orem 7
Redmond 7
Seattle 7
Bremen 6
Chicago 6
Guarulhos 6
Hyderabad 6
Macerata 6
Nürnberg 6
Paderno Dugnano 6
Pune 6
Turku 6
Wilmington 6
Baghdad 5
Chennai 5
Naples 5
Shanghai 5
Stockholm 5
Atlanta 4
Cattolica 4
Da Nang 4
Dearborn 4
Düsseldorf 4
Izmir 4
Johannesburg 4
Lancaster 4
Lisbon 4
Rio de Janeiro 4
Tianjin 4
Amsterdam 3
Belo Horizonte 3
Bogotá 3
Brussels 3
Chelsea 3
Hangzhou 3
Hillsboro 3
Kunming 3
Lappeenranta 3
London 3
Madrid 3
Mumbai 3
Newark 3
Palermo 3
Redwood City 3
Roubaix 3
Salvador 3
San Diego 3
San Mateo 3
Trieste 3
Warsaw 3
Washington 3
Zurich 3
Ancona 2
Ann Arbor 2
Appignano 2
Totale 1.460
Nome #
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 198
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 181
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 159
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients 150
The role of inflammatory bowel disease nurses for patients on biologic therapy during the COVID-19 pandemic 146
Therapy experiences and preferences among patients with anemia: Results of a cross-sectional survey among Italian patients with inflammatory bowel disease 143
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 129
Effect of a multistrain probiotic on leaky gut in patients with diarrhea-predominant irritable bowel syndrome (IBS-D): a pilot study 126
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 125
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 122
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 119
The awareness of the IBD nurse position among patients from an Italian tertiary IBD centre 115
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 113
Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period 110
Changes in the intestinal microbiota in patients with a major depressive episode and ulcerative colitis 107
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study 103
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study 93
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 86
Nonmedical switch of anti-TNF-α biosimilars has no major clinical, pharmacokinetic and psychological impact on patients with IBD - the SAFER Study 85
The educational role of IBD nurses in Italy in vaccinations: do not miss the moment for COVID-19 78
The inflammatory bowel disease care manager: Italian state of the art 74
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission 72
Impact of Psychopathology and Gut Microbiota on Disease Progression in Ulcerative Colitis: A Five-Year Follow-Up Study 6
Monitoring the psychopathological profile of inflammatory bowel disease patients treated with biological agents: a pilot study 5
Totale 2.645
Categoria #
all - tutte 11.173
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.173


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202288 4 1 6 4 3 3 1 6 0 18 21 21
2022/2023276 44 32 11 35 20 17 28 27 27 6 11 18
2023/2024248 9 35 20 17 12 40 19 7 15 17 29 28
2024/2025521 9 11 45 19 35 18 33 20 46 68 110 107
2025/20261.327 192 51 88 193 226 65 195 59 87 72 54 45
2026/20273 3 0 0 0 0 0 0 0 0 0 0 0
Totale 2.645